Cilastatin [cilastatin]
- Terms
-
Cilastatin Monosodium Salt
Cilastatin Sodium
MK 0791
MK-791
MK0791
A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4.
- DUI
- D015377 MeSH Browser
- CUI
- M0023687
- CAS
- 2-Heptenoic acid, 7-((2-amino-2-carboxyethyl)thio)-2-(((2,2-dimethylcyclopropyl)carbonyl)amino)-, (R-(R*,S*-(Z)))-
- Previous indexing
- Cyclopropanes (1983-1988); Dipeptidases/antagonists & inhibitors (1983-1988); Protease Inhibitors (1983-1988)
- History note
- 89
- Public note
- 89
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 1
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 1
- PD
- pharmacology 2
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 3
- TO
- toxicity
- UR
- urine
imipenem, cilastatin and relebactam Chemical MeSH Browser